Get started Log in

CEL — Celadon Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
£9.23m
Enterprise Value
£14.01m
Revenue
£0.08m

Final Results for the year ended 31 December 2022
05/06/2023 07:00
Brief: Celadon Pharma Entered Into A £7 Million Committed Credit Facility
30/05/2023 07:30
Notice of Results and Investor Presentation
26/05/2023 07:00
West Midlands Mayor Visits Celadon’s Facility
25/05/2023 07:00
Brief: Celadon Pharmaceuticals Enters Contract For Commercial Supply Of Pharmaceutical-Grade High-THC Cannabis Product
24/05/2023 08:00
Inaugural Supply Contract Win
24/05/2023 07:00
Celadon Pharma up on permit for commercial supply of medicinal cannabis product
14/03/2023 15:21
Brief: Celadon Pharma Says Approval In Place For Commercial Sale Of Pharma Cannabis Product
14/03/2023 15:03
Successful Update to Home Office Licence
14/03/2023 15:01
Notification of transaction by PDMR
10/02/2023 14:15
Change of Website Address
19/01/2023 07:00
Brief: Celadon Pharmaceuticals Says Midlands UK Facility Registered By MHRA For Good Manufacturing Practice
16/01/2023 07:33
Approval of GMP Registration by MHRA
16/01/2023 07:00
Brief: Celadon Pharmaceuticals Names Jonathan Turner As CFO
13/01/2023 07:27
Update on CFO Appointment
13/01/2023 07:00
Results of Feasibility Study
30/12/2022 07:00
Brief: Celadon Pharmaceuticals Makes Submissions To MHRA As Part Of Its GMP Registration
22/12/2022 08:03
Update on GMP Registration by MHRA
22/12/2022 07:00
Brief: Celadon Pharmaceuticals Names Jonathan Turner As CFO
01/11/2022 07:22
Appointment of CFO
01/11/2022 07:00